Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Dose Densified Chemoimmunotherapy With Early CNS Prophylaxis in Patients Less Than 65 Years With High Risk (aaIPI≥ 2) Diffuse Large B-Cell Lymphoma

NCT01325194 is registered in ClinicalTrials.gov with Nordic Lymphoma Group as lead sponsor.

NCT NCT01325194
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01325194 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Dose Densified Chemoimmunotherapy With Early CNS Prophylaxis in Patients Less Than 65 Years With High Risk (aaIPI≥ 2) Diffuse Large B-Cell Lymphoma
Lead sponsor
Nordic Lymphoma Group
Phase
Phase 2
Overall status
Completed
Start date
March 31, 2011
Completion date
December 31, 2019
Enrollment
143 (actual)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

primary disease